DigiPath, Inc. (OTCQB: DIGP), the independent digital pathology and cannabis testing, education, and media firm, has entered into a preferred supplier marketing and resource-sharing agreement with Blue Line Protection Group. The agreement was designed to create synergies between Blue Line's cannabis industry protection, compliance and transportation services, and DigiPath Labs' testing and analytical services of cannabis-based products and media distribution.
In this cooperative relationship, DigiPath Labs and Blue Line are expected to share certain resources in Colorado and other states where both companies will operate. Blue Line and DigiPath have also agreed to promote each other as a "preferred vendor" through direct product and service referrals and through advertisements on Blue Line Smart Ads, the revenue-generating interactive displays available for free to marijuana-related businesses.
"We're excited to be partnering with Blue Line, an established and well respected company in the cannabis space," said DigiPath Inc.'s CEO Todd Denkin. "We look forward to a symbiotic relationship of providing services for the cannabis industry, from a testing perspective, from a media distribution perspective, and from a patient security perspective."
This pooling of resources is expected to benefit customers of both companies by reducing costs and saving time.
"Combining our compliance, security and transportation services with DigiPath's reliable safety and potency tests will streamline the supply chain," explained Sean Campbell, Blue Line's Chief Executive Officer. "Everyone wins in this partnership, including dispensaries, growers, product producers, and patients."